Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines.

Diaceutics Chief Executive Officer Ryan Keeling says: ‘We have worked alongside KPMG leaders for many years with a strong admiration for their work in the precision medicine space. This alliance formally recognises our common goals and ambitions to collectively shape the future of precision medicine...[and] will make it easier for the world’s largest and most innovative pharmaceutical and biotech organisations to get access to the best expertise and the best data available.’

Current stock price: 97.64 pence, down 4.3% on Wednesday afternoon

12-month change: down 3.8%

Copyright 2024 Alliance News Ltd. All Rights Reserved.